BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10209720" target="_blank" >RIV/00064203:_____/13:10209720 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/13:10209720 RIV/00216208:11120/13:43907199
Result on the web
<a href="http://dx.doi.org/10.3109/10428194.2012.762514" target="_blank" >http://dx.doi.org/10.3109/10428194.2012.762514</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/10428194.2012.762514" target="_blank" >10.3109/10428194.2012.762514</a>
Alternative languages
Result language
angličtina
Original language name
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma
Original language description
The occurrence of Hodgkin lymphoma (HL) and a synchronous or metachronous form of non- Hodgkin lymphoma (NHL) in the same patient is rare [1]. The most frequent combination of the two is a diffuse large B-cell non-Hodgkin lymphoma (DLBCL) .
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia and Lymphoma
ISSN
1042-8194
e-ISSN
—
Volume of the periodical
54
Issue of the periodical within the volume
9
Country of publishing house
GB - UNITED KINGDOM
Number of pages
2
Pages from-to
2081-2082
UT code for WoS article
000323492400043
EID of the result in the Scopus database
—